STOCK TITAN

Cno Finl Group Inc Financials

CNO
FY2025 annual
Revenue $4.5B +0.9% YoY
Net Income $229.3M -45.5% YoY
EPS (Diluted) $2.30 -40.9% YoY
Free Cash Flow Not reported for FY2025
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Cno Finl Group Inc (CNO) reported $4.5B in revenue for fiscal year 2025, up 0.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CNO FY2025

Thin asset-level returns are being amplified by a highly leveraged balance sheet, making shareholder earnings swing harder than core operations.

FY2025 looks weaker on net income, but core operating capacity barely changed, with operating income essentially flat at $553M after $551M in FY2024. Operating cash flow still rose to $676M while net income fell to $229M, and lower interest expense points to volatility below the operating line rather than deterioration in the day-to-day franchise.

This is a balance-sheet-heavy model: FY2025 ended with $36.2B of liabilities against $2.6B of equity. Because leverage remained high, a drop in return on assets from 1.1% to 0.6% drove a disproportionate compression in shareholder returns, which is why modest asset-level slippage matters so much here.

Liquidity became less cushioned in FY2025 as cash fell from $2.0B to $984M. Share repurchases still reduced shares outstanding from 100.9M to 94.5M, so per-share results were supported even as total profit weakened.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Loss Ratio PremiumGrowth Capital Investment Yield CombinedRatio Stability 27 / 100
Financial Health Score 27/100
Scored as: Insurers peer group

Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Cno Finl Group Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Loss Ratio
11
Premium Growth
45
Capital
14
Investment Yield
0

Not available for Cno Finl Group Inc, and counted as zero in the overall score.

Combined Ratio
18
Stability
72
Piotroski F-Score Partial
4/6

Cno Finl Group Inc passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
2.95x

For every $1 of reported earnings, Cno Finl Group Inc generates $2.95 in operating cash flow ($675.7M OCF vs $229.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate
2.40x

Cno Finl Group Inc earns $2.40 in operating income for every $1 of interest expense ($553.2M vs $230.9M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$4.5B
YoY+0.9%
5Y CAGR+3.3%
10Y CAGR+1.6%

Cno Finl Group Inc generated $4.5B in revenue in fiscal year 2025. This represents an increase of 0.9% from the prior year.

EBITDA
$871.7M
YoY+3.4%
5Y CAGR+2.6%

Cno Finl Group Inc's EBITDA was $871.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 3.4% from the prior year.

Net Income
$229.3M
YoY-45.5%
5Y CAGR-5.3%
10Y CAGR-1.6%

Cno Finl Group Inc reported $229.3M in net income in fiscal year 2025. This represents a decrease of 45.5% from the prior year.

EPS (Diluted)
$2.30
YoY-40.9%
5Y CAGR+1.7%
10Y CAGR+5.2%

Cno Finl Group Inc earned $2.30 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 40.9% from the prior year.

Cash & Balance Sheet

Cash & Debt
$983.5M
YoY-50.8%
5Y CAGR-0.2%
10Y CAGR+2.1%

Cno Finl Group Inc held $983.5M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Dividends Per Share
$0.67
YoY+6.3%
5Y CAGR+7.3%
10Y CAGR+9.5%

Cno Finl Group Inc paid $0.67 per share in dividends in fiscal year 2025. This represents an increase of 6.3% from the prior year.

Shares Outstanding
94M
YoY-6.5%
5Y CAGR-6.9%
10Y CAGR-6.2%

Cno Finl Group Inc had 94M shares outstanding in fiscal year 2025. This represents a decrease of 6.5% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Margins & Returns

Operating Margin
12.3%
YoY0.0pp
5Y CAGR+0.2pp

Cno Finl Group Inc's operating margin was 12.3% in fiscal year 2025, reflecting core business profitability. That is unchanged from the prior year.

Net Margin
5.1%
YoY-4.4pp
5Y CAGR-2.8pp
10Y CAGR-2.0pp

Cno Finl Group Inc's net profit margin was 5.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 4.4 percentage points from the prior year.

Return on Equity
8.7%
YoY-8.0pp
5Y CAGR+3.2pp
10Y CAGR+2.2pp

Cno Finl Group Inc's ROE was 8.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 8.0 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Capital Allocation

Share Buybacks
$331.4M
YoY+10.4%
5Y CAGR+4.3%
10Y CAGR-1.0%

Cno Finl Group Inc spent $331.4M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 10.4% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Capital Expenditures

Not reported for fiscal year 2025.

CNO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CNO annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$4.6B$4.5B+0.9%$4.4B+7.3%$4.1B+15.9%$3.6B-13.2%$4.1B+7.9%$3.8B-4.8%$4.0B-6.9%$4.3B+0.4%$4.3B+7.8%$4.0B+4.5%$3.8B-8.0%$4.1B-7.4%$4.5B+3.1%$4.3B+5.3%$4.1B
Operating IncomeN/A$553.2M+0.4%$550.8M+19.9%$459.5M-1.5%$466.7M-9.3%$514.7M+11.0%$463.8M+25.9%$368.3M-3.4%$381.2M-16.2%$454.7MN/AN/AN/AN/AN/AN/A
Interest ExpenseN/A$230.9M-9.2%$254.4M+6.6%$238.6M+74.2%$137.0M+43.6%$95.4M-12.3%$108.8M-28.6%$152.3M+1.7%$149.8M+21.1%$123.7M+6.3%$116.4M+22.7%$94.9M+2.3%$92.8M-11.9%$105.3M-8.1%$114.6M+0.4%$114.1M
Income TaxN/A$64.1M-46.2%$119.1M+48.3%$80.3M-56.8%$185.9M+14.2%$162.8M+283.1%$42.5M+131.4%-$135.2M-369.3%$50.2M-83.5%$304.9M+6198.0%-$5.0M-105.2%$97.0M-21.6%$123.7M+171.4%-$173.2M-165.2%-$65.3M-121.4%-$29.5M
Net Income$279.6M$229.3M-45.5%$420.8M+52.2%$276.5M-56.2%$630.6M+10.6%$570.3M+89.0%$301.8M-26.3%$409.4M+230.0%-$315.0M-279.4%$175.6M-51.0%$358.2M+32.3%$270.7M+426.7%$51.4M-89.2%$478.0M+116.3%$221.0M-34.2%$335.7M
EPS (Diluted)$2.91$2.30-40.9%$3.89+62.1%$2.40-55.2%$5.36+23.2%$4.35+106.2%$2.11-19.2%$2.61+237.4%-$1.90-286.3%$1.02-49.3%$2.01+44.6%$1.39+479.2%$0.24-88.3%$2.06+148.2%$0.83-27.8%$1.15

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

CNO Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CNO annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$38.8B+2.5%$37.8B+8.1%$35.0B+5.7%$33.1B-8.5%$36.2B+2.4%$35.3B+5.1%$33.6B+7.0%$31.4B-5.0%$33.1B+3.5%$32.0B+2.7%$31.1B-0.1%$31.2B-10.4%$34.8B+1.9%$34.1B+3.7%$32.9B
Cash & Equivalents$983.5M-50.8%$2.0B+124.7%$889.0M+37.9%$644.9M-11.9%$731.7M-26.2%$991.9M+51.5%$654.7M-0.3%$656.6M-13.3%$757.3M+13.3%$668.2M-16.1%$796.7M+30.3%$611.6M-12.5%$699.0M+20.0%$582.5M+33.6%$436.0M
Total Liabilities$36.2B+2.3%$35.3B+7.7%$32.8B+4.6%$31.4B+1.4%$30.9B+3.6%$29.9B+3.1%$29.0B+3.2%$28.1B-0.7%$28.3B+2.8%$27.5B+1.9%$27.0B+2.0%$26.5B-11.3%$29.8B+2.6%$29.1B+2.7%$28.3B
Long-Term DebtN/AN/AN/AN/AN/AN/AN/A$916.8M+0.2%$914.6M+0.2%$912.9M-1.3%$925.0M+16.0%$797.1M-7.3%$860.0M-15.1%$1.0B+16.0%$873.2M
Total Equity$2.6B+4.9%$2.5B+13.5%$2.2B+25.3%$1.8B-52.0%$3.7B-32.8%$5.5B+17.3%$4.7B+38.7%$3.4B-30.5%$4.8B+8.0%$4.5B+8.4%$4.1B-11.7%$4.7B-5.4%$5.0B-1.9%$5.0B+9.4%$4.6B
Retained Earnings$2.4B+7.2%$2.3B+18.6%$1.9B+12.3%$1.7B+50.0%$1.1B+49.8%$752.3M+40.4%$535.7M+172.5%$196.6M-64.9%$560.4M-13.9%$650.7M+87.5%$347.1M+170.1%$128.5M+0.1%$128.4M+139.5%-$325.0M+38.9%-$532.1M

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities.

CNO Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CNO annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$698.9M$675.7M+7.6%$627.7M+7.7%$582.9M+17.7%$495.4M-17.2%$598.3M-18.7%$735.5M+5.6%$696.7M+119.2%$317.8M-49.8%$633.3M-18.4%$775.7M+3.7%$747.8M+514.0%$121.8M-83.1%$720.4M+13.5%$634.9M-18.1%$774.8M
Investing Cash Flow-$1.8B-$1.7B-12.0%-$1.5B-70.7%-$872.3M+51.0%-$1.8B-16.7%-$1.5B-150.8%-$608.4M-9.5%-$555.6M-5.7%-$525.7M-94.6%-$270.2M+71.0%-$930.4M+13.0%-$1.1B-1999.8%$56.3M+109.3%-$602.5M-205.7%-$197.1M+85.3%-$1.3B
Financing Cash Flow$1.6B-$22.6M-101.1%$2.0B+269.2%$533.5M-55.5%$1.2B+79.6%$667.6M+217.8%$210.1M+246.9%-$143.0M-233.4%$107.2M+139.1%-$274.0M-1145.8%$26.2M-81.6%$142.5M+153.7%-$265.5M-18864.3%-$1.4M+99.5%-$291.3M-168.2%$427.3M
Dividends Paid$66.4M$66.2M-2.2%$67.7M-0.6%$68.1M+5.1%$64.8M-1.4%$65.7M-1.9%$67.0M-0.1%$67.1M+3.5%$64.8M+8.7%$59.6M+8.8%$54.8M+5.4%$52.0M+2.0%$51.0M+109.0%$24.4M+75.5%$13.9M$0
Share Buybacks$255.0M$331.4M+10.4%$300.2M+80.7%$166.1M-12.6%$190.1M-53.4%$407.8M+52.0%$268.3M+5.4%$254.5M+135.6%$108.0M-35.8%$168.3M-19.9%$210.0M-42.5%$365.4M+14.5%$319.1M+169.5%$118.4M-34.3%$180.2M+158.2%$69.8M

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

CNO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

CNO annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Margin12.3%0.0pp12.4%+1.3pp11.1%-2.0pp13.1%+0.6pp12.5%+0.4pp12.1%+3.0pp9.2%+0.3pp8.8%-1.7pp10.6%N/AN/AN/AN/AN/AN/A
Net Margin5.1%-4.4pp9.5%+2.8pp6.7%-11.0pp17.6%+3.8pp13.8%+5.9pp7.9%-2.3pp10.2%+17.5pp-7.3%-11.4pp4.1%-4.9pp9.0%+1.9pp7.1%+5.9pp1.2%-9.4pp10.7%+5.6pp5.1%-3.0pp8.1%
Return on Equity8.7%-8.0pp16.7%+4.3pp12.5%-23.2pp35.6%+20.2pp15.5%+10.0pp5.5%-3.2pp8.8%+18.1pp-9.3%-13.0pp3.6%-4.4pp8.0%+1.4pp6.5%+5.4pp1.1%-8.6pp9.7%+5.3pp4.4%-2.9pp7.3%
Return on Assets0.6%-0.5pp1.1%+0.3pp0.8%-1.1pp1.9%+0.3pp1.6%+0.7pp0.9%-0.4pp1.2%+2.2pp-1.0%-1.5pp0.5%-0.6pp1.1%+0.3pp0.9%+0.7pp0.2%-1.2pp1.4%+0.7pp0.7%-0.4pp1.0%
Debt-to-Equity13.70-0.3x14.05-0.8x14.81-2.9x17.73+9.3x8.40+3.0x5.44-0.7x6.19+5.9x0.27+0.1x0.190.0x0.200.0x0.22+0.1x0.170.0x0.170.0x0.200.0x0.19

Not reported in any period shown, so not listed: Gross Margin, Current Ratio, FCF Margin.

Similar Companies

Frequently Asked Questions

What is Cno Finl Group Inc's annual revenue?

Cno Finl Group Inc (CNO) reported $4.5B in total revenue for fiscal year 2025. This represents a 0.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cno Finl Group Inc's revenue growing?

Cno Finl Group Inc (CNO) revenue grew by 0.9% year-over-year, from $4.4B to $4.5B in fiscal year 2025.

Is Cno Finl Group Inc profitable?

Yes, Cno Finl Group Inc (CNO) reported a net income of $229.3M in fiscal year 2025, with a net profit margin of 5.1%.

Cno Finl Group Inc (CNO) reported diluted earnings per share of $2.30 for fiscal year 2025. This represents a -40.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cno Finl Group Inc (CNO) had EBITDA of $871.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Cno Finl Group Inc (CNO) had an operating margin of 12.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Cno Finl Group Inc (CNO) had a net profit margin of 5.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Cno Finl Group Inc (CNO) paid $0.67 per share in dividends during fiscal year 2025.

Cno Finl Group Inc (CNO) has a return on equity of 8.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Cno Finl Group Inc (CNO) generated $675.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Cno Finl Group Inc (CNO) had $38.8B in total assets as of fiscal year 2025, including both current and long-term assets.

Yes, Cno Finl Group Inc (CNO) spent $331.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Cno Finl Group Inc (CNO) had 94M shares outstanding as of fiscal year 2025.

Cno Finl Group Inc (CNO) had a debt-to-equity ratio of 13.70 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Cno Finl Group Inc (CNO) had a return on assets of 0.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Cno Finl Group Inc (CNO) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Cno Finl Group Inc (CNO) has an earnings quality ratio of 2.95x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Cno Finl Group Inc (CNO) has an interest coverage ratio of 2.40x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Cno Finl Group Inc (CNO) scores 27 out of 100 on our Financial Health Score, indicating weak standing within its insurers peer group. The score is a 0-100 composite of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top